NYSE:COR

Cencora Stock Insider Trading

> Medical - Distribution

Buy COR

*Your capital is at risk

$311.34

-0.89 (-0.285%)

At Close: Jul 31, 2026

Cencora Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -5.17. In total, the insiders bought 382.97M and sold 125.13K COR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-5.17
● Buy	382.97M shares
● Sell	125.13K shares
73% Buy Activity Moderate Positive Correlation
Buy Signal Low Confidence Jun 29, 2026 Analysis Breakdown: Weakened by a contradictory negative Insider Power Score. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 17, 2025 Buy	Common Stock M-Exempt	Cleary James F Chief Financial Officer	C-Suite Officer	45 154 Value: $3.89M
Dec 17, 2025 Sell	Common Stock S-Sale	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	4 031 Value: $1.38M
Dec 17, 2025 Sell	Common Stock G-Gift	Mauch Robert P. President & CEO	CEO / President	3 000 Value: $0
Dec 17, 2025 Sell	Common Stock F-InKind	Cleary James F Chief Financial Officer	C-Suite Officer	26 952 Value: $9.28M
Dec 17, 2025 Buy	Non-qualified Stock Option (Right to Buy) M-Exempt	Cleary James F Chief Financial Officer	C-Suite Officer	45 154 Value: $3.89M
Dec 17, 2025 Sell	Common Stock G-Gift	Nally Dennis M Director	Director	1 173 Value: $0
Dec 15, 2025 Sell	Common Stock F-InKind	Mauch Robert P. President & CEO	CEO / President	638 Value: $223.5K
Dec 15, 2025 Buy	Common Stock M-Exempt	Mauch Robert P. President & CEO	CEO / President	638 Value: $223.5K
Dec 15, 2025 Buy	Restricted Stock Units M-Exempt	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	91 Value: $31.9K
Dec 15, 2025 Buy	Restricted Stock Units M-Exempt	Mauch Robert P. President & CEO	CEO / President	638 Value: $223.5K
Dec 15, 2025 Buy	Common Stock M-Exempt	Cleary James F Chief Financial Officer	C-Suite Officer	199 Value: $69.7K
Dec 15, 2025 Sell	Common Stock F-InKind	Cleary James F Chief Financial Officer	C-Suite Officer	199 Value: $69.7K
Dec 15, 2025 Buy	Restricted Stock Units M-Exempt	Cleary James F Chief Financial Officer	C-Suite Officer	199 Value: $69.7K
Dec 15, 2025 Buy	Common Stock M-Exempt	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	91 Value: $31.9K
Dec 15, 2025 Sell	Common Stock F-InKind	Krikorian Lazarus SVP & Chief Accounting Officer	Officer	91 Value: $31.9K
Nov 20, 2025 Buy	Restricted Stock Units M-Exempt	Battaglia Silvana Executive Vice President	CEO / President	932 Value: $337.4K
Nov 20, 2025 Sell	Common Stock F-InKind	Battaglia Silvana Executive Vice President	CEO / President	406 Value: $147.0K
Nov 20, 2025 Buy	Common Stock M-Exempt	Battaglia Silvana Executive Vice President	CEO / President	932 Value: $337.4K
Nov 20, 2025 Buy	Restricted Stock Units M-Exempt	Verma Pawan EVP, Chief Data & Info Officer	Officer	1 974 Value: $714.7K
Nov 20, 2025 Sell	Common Stock F-InKind	Verma Pawan EVP, Chief Data & Info Officer	Officer	1 010 Value: $365.7K
Nov 20, 2025 Buy	Common Stock M-Exempt	Verma Pawan EVP, Chief Data & Info Officer	Officer	1 974 Value: $714.7K
Nov 20, 2025 Buy	Restricted Stock Units M-Exempt	Campbell Elizabeth S Executive Vice President	CEO / President	1 590 Value: $575.7K
Nov 20, 2025 Sell	Common Stock F-InKind	Campbell Elizabeth S Executive Vice President	CEO / President	736 Value: $266.5K
Nov 20, 2025 Buy	Common Stock M-Exempt	Campbell Elizabeth S Executive Vice President	CEO / President	1 590 Value: $575.7K
Nov 20, 2025 Buy	Restricted Stock Units M-Exempt	Mauch Robert P. President & CEO	CEO / President	5 790 Value: $2.10M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CENCORA INC.

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alt...

Read Full Profile Here